Stem Cell Microvesicles: Potential Tools for Retinal Regeneration

干细胞微泡:视网膜再生的潜在工具

基本信息

  • 批准号:
    7534779
  • 负责人:
  • 金额:
    $ 19.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-12-01 至 2009-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The retina in lower vertebrates shows a remarkable regenerative ability that is lost in mammals. Multipotent progenitor cells, that are capable of differentiating into a variety of retinal cell types, have been isolated from the ciliary margin and retina of mammalian eyes. Despite their presence, these progenitor cells are normally quiescent and unable to regenerate damaged retina. This proposal will investigate the ability of microvesicles, released from mouse embryonic stem cells, to reactivate mouse retinal progenitor cells. The long term goal of this project is to discover novel ways of reactivating quiescent progenitor cell populations in the human eye, so that regeneration of damaged retina may be possible. Microvesicles are plasma-membrane particles that are released into the extracellular environment. Very recently, microvesicles have been reported from embryonic stem cells cultured in vitro. Our preliminary results show that these embryonic stem cell microvesicles contain RNA and protein. Most interestingly, they contain a specific class of RNA molecules called microRNAs, which are potent regulators of translation. Microvesicles may serve a role in intercellular communication in one of several manners. They may transfer microRNAs, mRNAs, or proteins to cells. Alternatively they can signal cells through surface proteins found on microvesicles. Our first aim is to characterize the RNA and protein contents of mouse embryonic stem cell microvesicles to look for candidates that might alter stem cell programming. We will use microarray analysis and qRT-PCR for mRNA and microRNA profiling, and mass spectrometry, Western blot analysis, and immunocytochemistry for protein profiling. We will also explore in Aim I the ability of these microvesicles to directly transfer RNA or protein to cells in vitro. Our second aim is to determine if these microvesicles can activate the quiescent stem cell population found in the ciliary margin and retina of mouse eyes. We will inject microvesicles into the aqueous, vitreous, and subretinal space of mice and look for increased proliferation of stem cells with BrDU- labeling. Our final aim is to look for endogenous microvesicles in the aqueous and vitreous and also to characterize them using microarray profiling, qRT-PCR, mass spectrometry, Western blot analysis, immunocytochemistry, and electron microscopy. The information generated in this proposal will not only lead to an increased understanding of the role that extrinsic mRNA, microRNAs, and proteins play in determining stem cell fate, but may also identify microvesicles as novel endogenous signaling factors in the eye, and possibly contributing to the stem cell niche.
描述(由申请人提供):低等脊椎动物的视网膜显示出在哺乳动物中丧失的显著的再生能力。多能祖细胞,能够分化成各种视网膜细胞类型,已经从哺乳动物眼睛的睫状缘和视网膜分离。尽管它们的存在,这些祖细胞通常是静止的,不能再生受损的视网膜。这项提议将研究从小鼠胚胎干细胞释放的微泡重新激活小鼠视网膜祖细胞的能力。该项目的长期目标是发现重新激活人眼中静止祖细胞群的新方法,从而使受损视网膜的再生成为可能。 微泡是释放到细胞外环境中的质膜颗粒。最近,已经报道了来自体外培养的胚胎干细胞的微泡。我们的初步结果表明,这些胚胎干细胞微泡含有RNA和蛋白质。最有趣的是,它们含有一类特殊的RNA分子,称为microRNA,这是翻译的有效调节因子。微泡可以以几种方式之一在细胞间通讯中起作用。它们可以将microRNA、mRNA或蛋白质转移到细胞中。或者,它们可以通过在微泡上发现的表面蛋白质向细胞发出信号。 我们的第一个目标是表征小鼠胚胎干细胞微泡的RNA和蛋白质含量,以寻找可能改变干细胞编程的候选者。我们将使用微阵列分析和qRT-PCR进行mRNA和microRNA分析,并使用质谱法、Western印迹分析和免疫细胞化学进行蛋白质分析。我们还将在Aim I中探索这些微泡在体外直接将RNA或蛋白质转移到细胞中的能力。我们的第二个目标是确定这些微泡是否可以激活小鼠眼睛睫状缘和视网膜中发现的静止干细胞群。我们将微泡注射到小鼠的房水、玻璃体和视网膜下腔中,并寻找BrDU标记的干细胞增殖增加。我们的最终目的是寻找内源性微泡在水和玻璃体,并使用微阵列分析,qRT-PCR,质谱,Western印迹分析,免疫细胞化学和电子显微镜来表征它们。在这个提议中产生的信息不仅会导致增加对外源性mRNA,microRNA和蛋白质在决定干细胞命运中所起作用的理解,而且还可能将微泡确定为眼睛中的新型内源性信号传导因子,并可能有助于干细胞生态位。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transfer of microRNAs by embryonic stem cell microvesicles.
  • DOI:
    10.1371/journal.pone.0004722
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Yuan A;Farber EL;Rapoport AL;Tejada D;Deniskin R;Akhmedov NB;Farber DB
  • 通讯作者:
    Farber DB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEBORA B FARBER其他文献

DEBORA B FARBER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEBORA B FARBER', 18)}}的其他基金

Stem Cell Microvesicles: Potential Tools for Retinal Regeneration
干细胞微泡:视网膜再生的潜在工具
  • 批准号:
    7360347
  • 财政年份:
    2007
  • 资助金额:
    $ 19.25万
  • 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
  • 批准号:
    6929014
  • 财政年份:
    2003
  • 资助金额:
    $ 19.25万
  • 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
  • 批准号:
    7084565
  • 财政年份:
    2003
  • 资助金额:
    $ 19.25万
  • 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
  • 批准号:
    6766784
  • 财政年份:
    2003
  • 资助金额:
    $ 19.25万
  • 项目类别:
Transgenic/Molecular Approaches for Ocular Albinism
眼部白化病的转基因/分子方法
  • 批准号:
    6702942
  • 财政年份:
    2003
  • 资助金额:
    $ 19.25万
  • 项目类别:
Pathfinding of Ganglion Cell Axons and Ocular Albinism
神经节细胞轴突与眼白化病的探路
  • 批准号:
    6417480
  • 财政年份:
    2001
  • 资助金额:
    $ 19.25万
  • 项目类别:
Pathfinding of Ganglion Cell Axons and Ocular Albinism
神经节细胞轴突与眼白化病的探路
  • 批准号:
    6525356
  • 财政年份:
    2001
  • 资助金额:
    $ 19.25万
  • 项目类别:
MOLECULAR MECHANISMS IN RETINAL DEGENERATIONS
视网膜变性的分子机制
  • 批准号:
    2162159
  • 财政年份:
    1989
  • 资助金额:
    $ 19.25万
  • 项目类别:
MOLECULAR MECHANISMS IN RETINAL DEGENERATIONS
视网膜变性的分子机制
  • 批准号:
    6705056
  • 财政年份:
    1989
  • 资助金额:
    $ 19.25万
  • 项目类别:
MOLECULAR MECHANISMS IN RETINAL DEGENERATIONS
视网膜变性的分子机制
  • 批准号:
    2654652
  • 财政年份:
    1989
  • 资助金额:
    $ 19.25万
  • 项目类别:

相似海外基金

The role of distal aqueous humor outflow tissue in glucocorticoid-induced glaucoma
远端房水流出组织在糖皮质激素诱发青光眼中的作用
  • 批准号:
    10667863
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
房水液体活检对视网膜母细胞瘤儿童分子预测和监测的验证。
  • 批准号:
    10718932
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
Regulation of aqueous humor flow by exosomal miRNA
外泌体 miRNA 对房水流动的调节
  • 批准号:
    23K09011
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of experimental basis to improve the prognosis of corneal transplantation in treating bullous keratoplasty due to pathological aqueous humor.
为改善角膜移植治疗病理性房水所致大疱性角膜移植术的预后奠定实验基础。
  • 批准号:
    23H03063
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Modulating aqueous humor outflow with engineered nanoparticles for glaucoma
用工程纳米颗粒调节房水流出以治疗青光眼
  • 批准号:
    10649763
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
  • 批准号:
    10510279
  • 财政年份:
    2022
  • 资助金额:
    $ 19.25万
  • 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
  • 批准号:
    10682543
  • 财政年份:
    2022
  • 资助金额:
    $ 19.25万
  • 项目类别:
ocular tissue response by intraocular pressure and aqueous humor in glaucoma - investigation for the mechanism and biomarkers of intraocular pressure regulation
青光眼中眼压和房水引起的眼组织反应——眼压调节机制和生物标志物的研究
  • 批准号:
    20H03839
  • 财政年份:
    2020
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
  • 批准号:
    10155489
  • 财政年份:
    2020
  • 资助金额:
    $ 19.25万
  • 项目类别:
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
  • 批准号:
    10405079
  • 财政年份:
    2020
  • 资助金额:
    $ 19.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了